Treatment of Resistant Hypertension: Cohort Study
Condition(s):Resistant HypertensionLast Updated:February 22, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Resistant HypertensionLast Updated:February 22, 2023Completed
Condition(s):Heart Failure; Diabetes Mellitus, Type 2Last Updated:March 15, 2024Completed
Condition(s):Heart FailureLast Updated:April 16, 2019Terminated
Condition(s):HyponatremiaLast Updated:December 15, 2016Terminated
Condition(s):Lymphoma; Myeloma; Leukemia; Myelodysplasia; Solid Tumors; Hodgkin’s Disease; MyelofibrosisLast Updated:May 16, 2014Completed
Condition(s):Acute Heart FailureLast Updated:October 19, 2023Recruiting
Condition(s):Acute Decompensated Heart FailureLast Updated:February 20, 2024Recruiting
Condition(s):Heart FailureLast Updated:April 13, 2023Suspended
Condition(s):Cardiovascular Risk FactorsLast Updated:December 29, 2023Completed
Condition(s):Diabetic Nephropathy; Persistent Proteinuria With Type II DiabetesLast Updated:June 1, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.